- Home
- MGPI vs PHAT Comparison
MGPI vs PHAT Comparison
Compare MGPI & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- PHAT
- Stock Information
- Founded
- MGPI 1941
- PHAT 2018
- Country
- MGPI United States
- PHAT United States
- Employees
- MGPI N/A
- PHAT N/A
- Industry
- MGPI Beverages (Production/Distribution)
- PHAT Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- PHAT Health Care
- Exchange
- MGPI Nasdaq
- PHAT Nasdaq
- Market Cap
- MGPI 626.9M
- PHAT 727.5M
- IPO Year
- MGPI 1988
- PHAT 2019
- Fundamental
- Price
- MGPI $31.04
- PHAT $9.40
- Analyst Decision
- MGPI Strong Buy
- PHAT Strong Buy
- Analyst Count
- MGPI 5
- PHAT 5
- Target Price
- MGPI $45.40
- PHAT $16.40
- AVG Volume (30 Days)
- MGPI 274.6K
- PHAT 2.4M
- Earning Date
- MGPI 07-31-2025
- PHAT 08-07-2025
- Dividend Yield
- MGPI 1.51%
- PHAT N/A
- EPS Growth
- MGPI N/A
- PHAT N/A
- EPS
- MGPI 0.50
- PHAT N/A
- Revenue
- MGPI $654,715,000.00
- PHAT $81,859,000.00
- Revenue This Year
- MGPI N/A
- PHAT $195.45
- Revenue Next Year
- MGPI N/A
- PHAT $106.76
- P/E Ratio
- MGPI $63.69
- PHAT N/A
- Revenue Growth
- MGPI N/A
- PHAT 3055.70
- 52 Week Low
- MGPI $25.12
- PHAT $2.21
- 52 Week High
- MGPI $92.52
- PHAT $19.71
- Technical
- Relative Strength Index (RSI)
- MGPI 56.45
- PHAT 58.44
- Support Level
- MGPI $31.24
- PHAT $8.19
- Resistance Level
- MGPI $33.38
- PHAT $10.13
- Average True Range (ATR)
- MGPI 1.17
- PHAT 0.70
- MACD
- MGPI 0.25
- PHAT -0.30
- Stochastic Oscillator
- MGPI 61.14
- PHAT 30.13
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.